Most patients with AD have a sporadic, late onset form, where the major risk factors are aging, type 2 diabetes (T2D) and apolipoprotein E ε4 (APOE-ε4) [10,11,12,13,14,15]. This evidence concerns the gene APOE and Alzheimer disease.